LEADER 05668nam 2200685 450 001 9910464892903321 005 20200520144314.0 010 $a1-59756-641-1 035 $a(CKB)3710000000122048 035 $a(EBL)1886741 035 $a(SSID)ssj0001261333 035 $a(PQKBManifestationID)11694218 035 $a(PQKBTitleCode)TC0001261333 035 $a(PQKBWorkID)11320753 035 $a(PQKB)11241036 035 $a(MiAaPQ)EBC1886741 035 $a(Au-PeEL)EBL1886741 035 $a(CaPaEBR)ebr10901621 035 $a(OCoLC)885279152 035 $a(EXLCZ)993710000000122048 100 $a20140813h20132013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMCI and Alzheimer's dementia $eclinical essentials for assessment and treatment of cognitive-communication disorders /$fKathryn A. Bayles, Cheryl K. Tomoeda ; Kimberly C. McCullough, contributor 210 1$aSan Diego, California :$cPlural Publishing, Inc.,$d2013. 210 4$dİ2013 215 $a1 online resource (xix, 209 pages) $cillustrations 300 $aDescription based upon print version of record. 311 $a1-59756-518-0 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aContents; Preface; Introduction; Acknowledgments; Contributors; Unit 1: Cognition, Memory, and Communication; Cognition and Memory; The "Company of Cognition"; Memory Defined; Sensory Memory; Working Memory; Long-Term Memory; Relation of Cognition and Memory to Communication; Production of Linguistic Information; Comprehension of Linguistic Information; Summary of Important Points; References; Unit 2: MCI: Minimal Cognitive Impairment; Mild Cognitive Impairment; Clinical Presentations of MCI; Prevalence of MCI in the Population; Diagnostic Criteria for MCI and AD; Conversion to Dementia 327 $aConversion Rate by MCI SubtypeNumber of Deficits and Conversion to Dementia; Risk and Protective Factors; Cognitive Deficits; Cognitive-Linguistic Deficits; Type of Language Changes; Summary; Summary of Important Points; References; Unit 3: Alzheimer's Dementia; Alzheimer's Disease; Diagnostic Criteria for AD; Neuropathology of AD; Risk Factors for AD; Age; Family History of AD; Less Education; History of Head Trauma; Loneliness; Gender; Maternal Age; Apolipoprotein E4 Allele; Minimal Cognitive Impairment; Predictors of Disease Progression; Protective Factors 327 $aEffects of AD on Cognitive and Communicative FunctionsEarly Stage; Middle Stage; Late-Stage AD; Summary of Important Points; References; Unit 4: Assessment of Cognitive-Communicative Function in Minimal Cognitive Impairment and Alzheimer's Dementia; Role of the Speech-Language Pathologist; The Process of Assessment; Prior to Testing; Review Medical History; Secure a Quiet, Well-Lit Test Environment; Testing; Check Vision; Check Hearing; Check Literacy; Be Alert to Depression; Be Alert to Adverse Drug Effects on Performance; Use Appropriate Tests; Assessment of MCI Due to AD; Screening for MCI 327 $aComprehensive Neuropsychological Approach to ScreeningAssessment of AD; Screening for AD; Comprehensive Assessment of AD; Summary of Important Points; References; Unit 5: Rationale for Therapy; Neuroplasticity; Memory Systems and Their Vulnerability to AD Pathology; Cognitive Reserve; Cognitive Stimulation Therapy Can Build Cognitive Reserve; Summary of Important Points; References; Unit 6: Cognitive Intervention and Minimal Cognitive Impairment; Different Forms of Cognitive Intervention Used in Individuals with MCI; Key Element 1: Base repetition focus on cognitive domains 327 $aComputer-Based TrainingKey Element 2: Provide direct training of strategies and functional skills.; Key Element 3: Empower clients with education regarding healthy aging and brain habits.; Key Element 4: Include opportunities for social engagement.; Conclusion; Summary of Important Points; References; Unit 7: Treatment: Direct Interventions; Definitions; Treatment Guidelines; Strategies for Successful Intervention; Facilitating Perception; Consider Span Capacity of Working Memory; Control of Task Complexity; Minimize Error Responses; Recognition Is Easier Than Recall 327 $aUse Retrieval Cues That Reflect Support Given at Encoding 330 $aThis book succinctly presents critical information about the cognitive-communicative disorders associated with mild cognitive impairment (MCI) and Alzheimer's disease (AD). It includes cutting-edge information about MCI, a very early stage of Alzheimer's disease, and the role of speech-language pathologists (SLPs) in early identification and behavioral and/or pharmacologic treatments. Clinical essentials-definitions, assessments, and treatments-for MCI and AD are also covered. 606 $aAlzheimer's disease$xDiagnosis 606 $aAlzheimer's disease$xTreatment 606 $aMild cognitive impairment$xDiagnosis 606 $aMild cognitive impairment$xTreatment 608 $aElectronic books. 615 0$aAlzheimer's disease$xDiagnosis. 615 0$aAlzheimer's disease$xTreatment. 615 0$aMild cognitive impairment$xDiagnosis. 615 0$aMild cognitive impairment$xTreatment. 676 $a616.8/31 700 $aBayles$b Kathryn A.$f1942-$0995351 702 $aTomoeda$b Cheryl K. 702 $aMcCullough$b Kimberly C. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910464892903321 996 $aMCI and Alzheimer's dementia$92280404 997 $aUNINA